At thromboDx BV we develop blood platelet-powered molecular cancer diagnostics tests. These non-invasive tests enable longitudinal monitoring of the mutational status of the tumor in blood. The changing mutational tumor profile can be monitored in blood platelets allowing for personalized tumor therapy.
Blood platelets can provide a reservoir for nucleic acids derived from infected cells, including viral, bacterial, and fungal RNA and/or DNA nucleic acids. We are actively seeking partners for the co-development of platelet-powered diagnostics of infectious diseases.
Maternal blood platelets can provide a reservoir for foetal nucleic acids. We are actively seeking partners for the co-development of platelet-powered prenatal diagnostics.